Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 37, Issue 1, 2004, Pages 74-75

  Lambertuccil, José Roberto ^a   Mourao França, Bruno ^a   De Melo Queiroz, Elisa ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; MEGLUMINE ANTIMONATE;

ACUTE PANCREATITIS; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; HOSPITAL DISCHARGE; HUMAN; LEISHMANIA; MALE; PARASITE IDENTIFICATION; PHYSICAL EXAMINATION; STOMACH SUCTION; VISCERAL LEISHMANIASIS;

EID: 1442276557     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822004000100022     Document Type: Article

References (3)

1. Delgado J, Macías J, Pineda JA, Corzo, JE, González-Moreno MP, De La Rosa R, Sanchez-Quijano A, Leal M, Lissen E. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1 infected patients. The American Journal of Tropical Medicine and Hygiene 61:766-769, 1999.
2. Gasser RA, Magill AJ, Oster CN, Franke ED, Grögl M, Berman JD. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clinical Infectious Diseases 18:83-90, 1994.
3. Prala A, Silva-Vergara, Leon M, Costa L, Rocha A, Krolewiecki A, Silva JC, Paula EV, Pimenta Junior FG, Giraldo LER. Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. Revista da Sociedade Brasileira de Medicina Tropical 36:65-69, 2003.